Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Anderogenetic Alopecia
Conditions: Androgenetic Alopecia Interventions: Drug: Exosomes GFC CELL EXO SCALP KIT (Leuco Exo 97%) Sponsors: Services Hospital, Lahore Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia
Conditions: Androgenetic Alopecia Interventions: Biological: Exosomes GFC CELL EXO SCALP KIT (Leuco Exo 97%); Biological: Platelet Rich Plasma Sponsors: Services Hospital, Lahore Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia
Conditions: Androgenetic Alopecia Interventions: Procedure: microneedling; Procedure: Autologous Concentrated Growth Factor; Drug: 5% minoxidil Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia
Conditions: Androgenetic Alopecia Interventions: Device: ablative fractional 2940-nm Er: YAG laser; Device: non-ablative fractional 1565nm; Drug: 5% Minoxidil Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
Conditions: Breast Cancer; Early-stage Breast Cancer; Hair Loss; Alopecia; Chemotherapy-induced Alopecia Interventions: Device: Amma Portable Scalp Cooling System (PSCS); Other: Questionnaires Sponsors: University of California, San Francisco; Cooler Heads Care Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
Conditions: Frontal Fibrosing Alopecia; Lichen Planopilaris Interventions: Drug: Tofacitinib 5 MG Sponsors: Institute of Dermatology, Thailand Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
The Effect of 24-week Dietary Intake of Food Supplements on Hair
Conditions: Hair Thinning; Hair Loss Interventions: Dietary Supplement: Investigational product 1 (CPMSM); Dietary Supplement: Investigational product 2 (HC+); Dietary Supplement: Placebo Sponsors: VIST - Faculty of Applied Sciences; Slovenian Research and Innovation Agency; Tosla d.o.o. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata
Conditions: Extensive Alopecia Areata Interventions: Drug: Oral Tofacitinib citrate Sponsors: Services Institute of Medical Sciences, Pakistan Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial
This study determines the efficacy of low-level light therapy for the prevention of chemotherapy-induced hair loss for patients with breast cancer using a randomized controlled trial.MethodsOne hundred six eligible breast cancer patients were randomly distributed into a low-level light therapy group and a control group, after receiving chemotherapy. Subjects in the low-level light therapy group received 12 courses of intervention within 4 weeks. Subjects in the control group received no intervention but were closely monitored.The primary outcome is measured as the difference in the hair count in a target area between the b...
Source: Trials - December 5, 2023 Category: Research Source Type: clinical trials
Excimer Light(308) Therapy for Resistant Alopecia Areata
Conditions: Alopecia Areata Interventions: Device: excimer light Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss
Conditions: Androgenetic Alopecia Interventions: Device: NTAP Sponsors: Dr. Peter C. Friedman Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation
Conditions: Alopecia Scar Interventions: Procedure: follicular unit extraction and implantaion Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Phase III Study of KX-826 With Adult Male Patients With AGA
Conditions: Androgenetic Alopecia Interventions: Drug: KX-826- （5%） BID; Other: Placebo Sponsors: Suzhou Kintor Pharmaceutical Inc,; Suzhou Koshine Biomedica, Inc. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health
Conditions: Hair Health; Hair Loss Interventions: Dietary Supplement: Hair Nutra Growth Supplement& Hair Nutra Boost Supplement; Dietary Supplement: Hair Nutra Growth Sponsors: BrandiZone; Citruslabs Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia
Conditions: Androgenetic Alopecia Interventions: Drug: placebo-Q2W; Drug: HMI-115-120mg-Q4W; Drug: HMI-115-240mg-Q4W; Drug: HMI-115, 240mg-Q2W Sponsors: Hope Medicine (Nanjing) Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
